☝ A “𝐇𝐢𝐝𝐝𝐞𝐧” 𝑶𝒑𝒑𝒐𝒓𝒕𝒖𝒏𝒊𝒕𝒚 𝒐𝒏 𝑾𝒂𝒍𝒍 𝑺𝒕𝒓𝒆𝒆𝒕… ☝

If Big Pharma wants to keep control of the market, they have to buy out Small Pharma companies.

Editor's Note: At Take The Trades, we are serious about being your "eyes and ears" for special opportunities for you to take advantage of. The message below from one of our partners is one we think you should take a close look at. Hello Friend! Looking for the best "hidden" opportunity on Wall Street? While most investors have been focused on crypto and pot stocks, we've been one of the few to stay focused on the biotech sector… And there has been a different biotech stock being taken over every 56 days… So, I hope you made some good money off of our work! But with a potentially huge merger on the way, I wanted to do something a bit different today… And tell you where this big merger is coming from. It started over 30 years ago, with the Human Genome Project (HGP), an international project that aimed to map out the human genome. This project led scientists to identify mutations linked to different types of cancer. This, in turn, led to them designing new medications to treat them. This is the part of the story that gets REALLY interesting… Because 75% of cancer drugs are still old chemical drugs. For example, the drug Cytarbine is still used for Leukemia…and it was patented way back in 1960. Think about how much medicine has changed since then. That's why patients are still stuck with horrendous side effects like vomiting, bone marrow suppression, diarrhea, rashes, bleeding, mouth ulcers and liver problems. I know many of you have dealt with this first-hand… Having either gone through chemo yourself or having watched a loved one go through it. For those who haven't, let me tell you… It is a BRUTAL experience. That's why they created the saying "the chemo will get you before the cancer does." But there's good news here… Because the HGP has allowed scientists to use precision-medicine techniques to design new treatments… And now, there is a "NEW WAY" to fight cancer. But this isn't only good for patients… It's also beneficial for takeover investors. The money spent on cancer therapies in 2018 was a whopping $140 billion… And 75% of that was spent on the "OLD WAY" of fighting the disease. Looking at how fast the world moves… How long can that last? How long until 75% is spent on the "NEW WAY" of treating the disease? I don't see it being a very long time. Right now, Big Pharma has the "OLD WAY" market locked down… But a new crop of small biotech firms are creating the "NEW WAY"… And you know Big Pharma won't be happy about it. One of these tiny biotech firms invented a new treatment for Leukemia that targets patients by their genetic profile… And that's a big threat to companies like Bristol Myers and Novartis… Which is why this tiny company is our top takeover target of the month. See, here's the thing… If Big Pharma wants to keep control of the market, they have to buy out Small Pharma companies. This is why we've done so well riding the biotech wave. Pfizer bought a small firm called Array Biopharma last month for $48 a share…a whopping 144% gain from our recommended price point of $18.90. Glaxo bought Tesaro for $74.96…a nice 93% gain from our recommended price of $38.41. Eli Lilly bought Loxo Oncology for $234.66…which was a 78% gain from our recommended price of $131.02. Illumina bought diagnostic firm Pacific Biosciences for $8…a strong 82% gain from our recommended price of $4.38. And the list goes on and on… Which "NEW WAY" company will get acquired next? Click here to see what biotech firm we think will be bought out next…and why we predict it could bring big gains to fast-acting investors. "The Buck Stops Here" Dylan Jovine Chairman Behind the Markets You indra21poetra@gmail.com received this email as a result of your consent to receive 3rd party offers at our another website. This ad is sent on behalf of Behind The Markets, 4181 NW 1st Ave #8, Boca Raton, FL 33431. If you would like to unsubscribe from receiving offers from Behind The Markets please click here. If you have received this message in error, kindly ignore or unsubscribe below. To not miss out on any of our emails, be sure to whitelist us. Follow our instructions About Us | Privacy Policy | Terms & Conditions | Unsubscribe 221 E Indianola Ave, Phoenix, AZ 85012 © 2022 Take The Trades. All Rights Reserved.